Oncology & Immunology
High-value and increasingly India's growth engine, from oral targeted therapies to biosimilar monoclonal antibodies.
What This Class Covers
Oncology is one of the fastest-growing categories in Indian pharma export, spanning cytotoxics, targeted oral therapies (TKIs), hormonal agents and a fast-expanding roster of biosimilar monoclonal antibodies. Cytotoxic manufacture requires dedicated facilities separate from general solid-dose lines, and several molecules require an Export NOC before shipment.
Export Status Notes
Several molecules require a CDSCO Export NOC; lenalidomide and thalidomide carry destination-specific pregnancy-prevention programme obligations.
Full Molecule List
5-Fluorouracil
Abemaciclib
Abiraterone
Acalabrutinib
Adalimumab (biosimilar)
Ado-trastuzumab emtansine
Afatinib
Alectinib
Alpelisib
Amifostine
Anastrozole
Apalutamide
Aprepitant
Arsenic trioxide
Atezolizumab
Axitinib
Azacitidine
Belinostat
Bendamustine
Bevacizumab (biosimilar)
Bicalutamide
Bleomycin
Bortezomib
Bosutinib
Brentuximab vedotin
Brigatinib
Busulfan
Cabazitaxel
Cabozantinib
Capecitabine
Carboplatin
Carfilzomib
Carmustine
Ceritinib
Cetuximab (biosimilar)
Chlorambucil
Cisplatin
Cladribine
Clofarabine
Crizotinib
Cyclophosphamide
Cytarabine
Dacarbazine
Dacomitinib
Dactinomycin
Daratumumab
Darbepoetin alfa
Darolutamide
Dasatinib
Daunorubicin
Decitabine
Degarelix
Denosumab
Dexrazoxane
Docetaxel
Doxorubicin
Durvalumab
Eltrombopag
Enasidenib
Enzalutamide
Epirubicin
Eribulin
Erlotinib
Erythropoietin
Etanercept (biosimilar)
Etoposide
Everolimus
Exemestane
Filgrastim
Fludarabine
Flutamide
Fosaprepitant
Fulvestrant
Gefitinib
Gemcitabine
Gilteritinib
Goserelin
Hydroxyurea
Ibandronate
Ibrutinib
Icotinib
Idarubicin
Idelalisib
Ifosfamide
Imatinib
Interferon alfa-2b
Ipilimumab
Irinotecan
Ivosidenib
Ixabepilone
L-Asparaginase
Lanreotide
Lenalidomide
Lenograstim
Lenvatinib
Letrozole
Leucovorin (folinic acid)
Leuprolide
Liposomal Doxorubicin
Lomustine
Lorlatinib
Megestrol acetate
Melphalan
Mercaptopurine
Mesna
Methotrexate
Midostaurin
Mitomycin C
Mitoxantrone
Nab-Paclitaxel
Nelarabine
Netupitant + Palonosetron
Nilotinib
Nilutamide
Nintedanib
Niraparib
Nivolumab
Obinutuzumab
Octreotide
Ofatumumab
Olaparib
Osimertinib
Oxaliplatin
Paclitaxel
Palbociclib
Pamidronate
Panobinostat
Pazopanib
Pegaspargase
Pegfilgrastim
Pembrolizumab
Pemetrexed
Pertuzumab (biosimilar)
Plerixafor
Pomalidomide
Ponatinib
Procarbazine
Raltitrexed
Rasburicase
Regorafenib
Ribociclib
Rituximab (biosimilar)
Romidepsin
Romiplostim
Rucaparib
Ruxolitinib
Sorafenib
Sunitinib
Talazoparib
Tamoxifen
Temozolomide
Temsirolimus
Thalidomide
Thalidomide (myeloma)
Thioguanine
Tocilizumab (biosimilar)
Topotecan
Trastuzumab (biosimilar)
Tretinoin (ATRA)
Triptorelin
Vandetanib
Venetoclax
Vinblastine
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorinostat
Zanubrutinib
Zoledronic acid
No molecules match your search.
Showing 170 of 170 molecules tracked in this class. Contact us for a specific molecule not listed here.
Prescription Breakdown
- OTC
- 0
- Prescription (Rx)
- 167
- Restricted / Controlled
- 3
Need a Molecule Not Listed Here?
Our manufacturing-partner network covers a broad range beyond this catalogue. Send us your requirement.